Back

Bleeding risk and healthcare resource utilisation in elderly patients treated with edoxaban or vitamin K antagonists for atrial fibrillation in Italy

24 April 2021 (07:30 - 08:30)
Organised by:
Congress Presentation Part of: Optimal therapy of atrial fibrillation Treatment EHRA Premium Access EHRA 2021

About the speaker

Photo
Ms Elisabeth Smits

Pharmo Institute, Utrecht (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Achieving acute mitral isthmus block with catheter ablation with vein of marshall ethanol infusion
Doctor M. Andronache (Clermont-Ferrand, FR)
Abstract Slides Video
Presentation thumbnail
Antiarrhythmic drug responders among patients with recurrent atrial fibrillation after catheter ablation
Doctor Y. Park (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
Esophagus-to-posterior Atrial wall relationship: pre- and Intra-procedural three-dimensional multimodality imaging for esophageal position.
Doctor C. Teres (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Polypharmacy and major adverse events in atrial fibrillation
Doctor A. Papazoglou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
The magnitude and the course of local impedance drop to guide successful AF ablation: insight from an Italian registry
Doctor V. Schillaci (Mercogliano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Optimal therapy of atrial fibrillation

The Event

Event poster

EHRA 2021

24 April 2021 07:30 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Presentation
AF-CARE: “R” Rate and rhythm control

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources